missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. DGCR8 Antibody, Novus Biologicals™
  7. 18649594

DGCR8 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP3-21407-25ul

 View more versions of this product

Product Code. 18649594

  • 450.00 € / 25µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

DGCR8 Polyclonal antibody specifically detects DGCR8 in Human samples. It is validated for Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

DGCR8
Polyclonal
Immunocytochemistry/Immunofluorescence 0.25-2 ug/ml
C22orf12, DGCRK6chromosome 22 open reading frame 12, DiGeorge syndrome critical region 8, DiGeorge syndrome critical region gene 8, Gy1, microprocessor complex subunit DGCR8, pasha
This antibody was developed against Recombinant Protein corresponding to amino acids: IDGVTYGSGTASSKKLAKNKAARATLEILIPDFVKQTSEEKPKDSEELEYFNHISIEDSRVYELTSKAGLLSPYQILHECLKRNHGMGDTSIKFEVVPG
25 μg
Epigenetics, Stem Cell Markers
54487
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
IgG
Immunofluorescence
Unconjugated
PBS, pH 7.2, 40% glycerol
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.